Evidence map›Paper›PMID 32548231›Full record

ArticleGynecologic oncology reports2020

Paraneoplastic Raynaud phenomenon associated with metastatic ovarian cancer: A case report and review of the literature.

Tiffany S Lai, Man R Shim, David Shin, Mae Zakhour

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Gynecologic oncology reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Raynaud's Phenomenon with Focus on Systemic Sclerosis.Journal of clinical medicine · 2022
    Review
  4. Article
  5. Article
  6. Article
  7. Paraneoplastic Raynaud's Phenomenon as an Initial Manifestation of Lung Cancer?European journal of case reports in internal medicine · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Tiffany S LaiDepartment of Obstetrics and Gynecology, Division of Gynecologic Oncology, David Geffen School of Medicine, UCLA, Los Angeles, CA, United States.
Man R ShimDepartment of Medicine, Division of Rheumatology, David Geffen School of Medicine, UCLA, Los Angeles, CA, United States.
David ShinDepartment of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, UCLA, Los Angeles, CA, United States.
Mae ZakhourDepartment of Obstetrics and Gynecology, Division of Gynecologic Oncology, David Geffen School of Medicine, UCLA, Los Angeles, CA, United States.
University of California, Los Angeles · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

•Paraneoplastic syndromes are rarely associated with ovarian malignancies.•Paraneoplastic syndromes may be the presenting symptom of an underlying malignancy.•Rheumatologic disorders with unusual presentations may be malignancy related.•These rheumatologic disorders are often refractory to standard treatments.

Indexed as

Ovarian cancerParaneoplastic syndromesRheumatologic disorders

Identifiers

PMID32548231
PMCPMC7284054
OpenAlexW3020250175

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.